Enhancing and Strengthening the Excellence in Interdisciplinary Biomedical Research at TRANSCEND

Informations projet

ESEI-BioMed

N° de convention de subvention: 952390

DOI

10.3030/952390

Date de signature de la CE 10 Juin 2020

Date de début 1 Janvier 2021

Date de fin 31 Decembre 2026

Financé au titre de

• Establishing ‚ERA Chairs’

Coût total

€ 2 500 000,00

Contribution de l’UE

€ 2 500 000,00

Coordonné par

INSTITUTUL REGIONAL DE ONCOLOGIE IASI
Romania

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (12)

Equipment upgrading 2

A report on the acquisition of the new equipment and the related training will be produced and delivered to the EC in accordance with the time planning (M24). Since a key equipment is mandatory to be acquired as soon as possible, as explained in the Methodology, a report on the equipment upgrading will be also provided at M12.

Website of the project

website of the ESEI-BioMed project will be launched M1. A report on the website creation will be provided to the EC in parallel with the reports planned for M24.

Organization of events 1

A report describing the organization of events at national level necessary to communicate and promote the project to broad audience will be produced and provided to the EC for each reporting period (M24, M56 and M72).

Scientific outputs 1

A report describing the scientific progress, achievements and results of the project will be produced and delivered to the EC in accordance with the time plan (M40, M56 and M72).

Organization of meetings 1

A report describing the organization of events at national level necessary to establish national collaborations will be produced and provided to the EC for each reporting period (M24, M56 and M72).

Articles and patents 1

A report on all manuscript submitted, articles published and patent applications will be produced and provided to the EC for each reporting period (M40, M56, M72). At least 10 publications (open access included) in peer-reviewed journals and 2 patent applications are foreseen for this project.

Visits in the European laboratories 1

A report describing the the visits made in the European laboratories by the team members will be produced and published on the website of the project. It will also be provided to the EC for each reporting period (M40, M56 and M72).

Promotion materials 1

A report describing all the promotion materials elaborated during the project run will be produced and provided to the EC for each reporting period M12 M40 and M72

Promotion materials 2

A report describing all the promotion materials elaborated during the project run will be produced and provided to the EC for each reporting period (M12, M40 and M72).

Dissemination, communication and promotion (DCP) plan 1

A reporting describing the strategy and means by which the ESEI-BioMed will reach the entire community will be produced and reported to the EC in accordance with the time plan (M24, M56). The plan will be also discussed with IAB members.

Equipment upgrading 1

A report on the acquisition of the new equipment and the related training will be produced and delivered to the EC in accordance with the time planning M24 Since a key equipment is mandatory to be acquired as soon as possible as explained in the Methodology a report on the equipment upgrading will be also provided at M12

Participation in scientific meetings 1

A report describing the participation in at national and international scientific meetings will be produced and published on the website of the project. It will also be provided to the EC for each reporting period (M24, M56 and M72).

Publications

Peer reviewed articles (12)

Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue

Auteurs: Roxana-Maria Amarandi; Alina Ibanescu; Eugen Carasevici; Luminita Marin; Brindusa Dragoi
Publié dans: Pharmaceutics, Numéro 1, 2022, ISSN 1999-4923
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14020308

Synthesis of ZnO/Au Nanocomposite for Antibacterial Applications

Auteurs: Violeta Dediu, Mariana Busila, Vasilica Tucureanu, Florentina Ionela Bucur, Florina Silvia Iliescu, Oana Brincoveanu, Ciprian Iliescu
Publié dans: Nanomaterials, Numéro 12, 2024, Page(s) 3832, ISSN 2079-4991
Éditeur: MDPI
DOI: 10.3390/nano12213832

NHF-derived carbon dots: prevalidation approach in breast cancer treatment

Auteurs: Crina Elena Tiron, Gabriel Luta, Mihail Butura, Florin Zugun-Eloae, Corneliu S. Stan, Adina Coroaba, Elena-Laura Ursu, Gabriela Dumitrita Stanciu, Adrian Tiron
Publié dans: Scientific Reports, Numéro 10/1, 2020, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/s41598-020-69670-z

Mn-based 2D layered nanomaterials for boosting the MRI signal

Auteurs: Brindusa Dragoi, Cristina Mariana Uritu, Laurentiu Agrigoroaie, Doina Lutic, Thomas Cacciaguerra, Vasile Hulea, Eugen Carasevici
Publié dans: Materials Letters, Numéro 288, 2021, Page(s) 129331, ISSN 0167-577X
Éditeur: Elsevier BV
DOI: 10.1016/j.matlet.2021.129331

Erythromycin Formulations—A Journey to Advanced Drug Delivery

Auteurs: Vera-Maria Platon, Brindusa Dragoi, Luminita Marin
Publié dans: Pharmaceutics, Numéro 14, 2024, Page(s) 2180, ISSN 1999-4923
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14102180

Impact of Lipid Composition on Vesicle Protein Adsorption: A BSA Case Study

Auteurs: Roxana-Maria Amărandi, Andrei Neamṭu, Rareş-Ionuṭ Ştiufiuc, Luminiṭa Marin, Brînduşa Drăgoi
Publié dans: ACS Omega, Numéro 9, 2024, Page(s) 17903-17918, ISSN 2470-1343
Éditeur: American Chemical Society
DOI: 10.1021/acsomega.3c09131

Engineering the Morphostructural Properties and Drug Loading Degree of Organic–Inorganic Fluorouracil–MgAl LDH Nanohybrids by Rational Control of Hydrothermal Treatment

Auteurs: Alina Ibanescu, Dragos-Ioan Olariu, Doina Lutic, Vasile Hulea, Brindusa Dragoi
Publié dans: ACS Omega, Numéro 8, 2023, Page(s) 26102-26121, ISSN 2470-1343
Éditeur: American Chemical Society
DOI: 10.1021/acsomega.3c02288

Understanding DNA Epigenetics by Means of Raman/SERS Analysis for Cancer Detection

Auteurs: Luca David, Anca Onaciu, Valentin Toma, Rareș-Mario Borșa, Cristian Moldovan, Adrian-Bogdan Țigu, Diana Cenariu, Ioan Șimon, Gabriela-Fabiola Știufiuc, Eugen Carasevici, Brîndușa Drăgoi, Ciprian Tomuleasa, Rareș-Ionuț Știufiuc
Publié dans: Biosensors, Numéro 14, 2024, Page(s) 41, ISSN 2079-6374
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/bios14010041

Entrapment of N-Hydroxyphthalimide Carbon Dots in Different Topical Gel Formulations: New Composites with Anticancer Activity

Auteurs: Corina-Lenuta Savin, Crina Tiron, Eugen Carasevici, Corneliu S. Stan, Sorin Alexandru Ibanescu, Bogdan C. Simionescu, Catalina A. Peptu
Publié dans: Pharmaceutics, Numéro 11/7, 2019, Page(s) 303, ISSN 1999-4923
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics11070303

Magnetic Nanoparticles: Synthesis, Characterization, and Their Use in Biomedical Field

Auteurs: Gabriela Fabiola Stiufiuc, Rares Ionut Stiufiuc
Publié dans: Applied Sciences, Numéro 14, 2024, Page(s) 1623, ISSN 2076-3417
Éditeur: MDPI
DOI: 10.3390/app14041623

MnAl-Layered Double Hydroxide Nanosheets Infused with Fluorouracil for Cancer Diagnosis and Therapy

Auteurs: Brindusa Dragoi, Cristina Mariana Uritu, Laurentiu Agrigoroaie, Doina Lutic, Vasile Hulea, Georgeta Postole, Adina Coroaba, Eugen Carasevici
Publié dans: ACS Applied Nano Materials, 2021, ISSN 2574-0970
Éditeur: American Chemical Society
DOI: 10.1021/acsanm.0c03365

Microfluidic trends in drug screening and drug delivery

Auteurs: Jianguo Feng, Jiri Neuzil, Andreas Manz, Ciprian Iliescu, Pavel Neuzil
Publié dans: TrAC Trends in Analytical Chemistry, Numéro 158, 2023, Page(s) 116821, ISSN 0165-9936
Éditeur: Elsevier BV
DOI: 10.1016/j.trac.2022.116821